Press Releases about Lexaria Bioscience Corp
Lexaria (NASDAQ: LEXX) Advances Human Nicotine Study, Announces New Program with Altria
April 19, 2022
Topics
Intellectual Property
Exposures
Intellectual Property
Via AccessWire
Lexaria Provides Update on Human Nicotine Study NIC-H22-1
April 12, 2022
Via AccessWire
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Begins DehydraTECH-CBD Epilepsy Research Program
March 15, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|